Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: wvalx who wrote (19372)	3/8/1999 9:20:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

Vivus is up 120% but as a long term stock holder I say SO WHAT. I say that Vivus made a miniscule gain today and now is only a mere 88.5% BELOW its all time high of 41 7/8. Here we have a REAL company with a REAL product that is still barely launched on a global scale and as of today at 4 13/16 we are still well below our 1994 IPO price in the 7's. Intraurethral patents galore, Alibra in phase III, Dr Christ's gene therapy, now the clit cream and more in the works. How can one justify a $4 stock(let alone a $2.00 stock) after all the progress made over the past 4 years? LW may have blown it bad on managing Vivus' interests in the face of Viagra but it still doesn't change the scientific progress made over the past several years. Still mad as hell and wont be even slightly happy until we start seeing some REAL price recovery!